Bangalore, Feb 21 (UNI) Finland based Raisio Nutrition Limited, will introduce its popular Cholesterol reducing product, Benecol, into India and Asia with a business partneship with the city based British Biologicals a leading nutritional supplements company of India.
Addressing newspersons here today Mr Mikkao Laavainen, Director, Raisio Nutrition Limited said that Raisio had entered into a business partnership with British Biologicals, and launch its Plant Stanon Ester 'Benecol' under the brand name Colred Benecol, a nutritional product, a supplement which reduce cholesterol naturally.
He said that Raisio had selected Bangalore based British Biolobicals, one of the top Indian company in nutraceuticals which manufactures varied products including B-Protin, D-Protin and Medi-Slim, to manufacture and market its product Colred Benecol in India and Asian Market.
Mr Laavainen also said that Raisio enjoyed over 30 per cent of the one billion USD global market of cholesterol reducing products with Europe was the predominant market. It is now being introduced in Asia, Africa and other Latin American countries, he said.
Rasio's Plant Stanol Ester-Benecol has proved its efficacy in controlling elevated cholesterol in 40 randomised controlled global clinical trials. There were no adverse effects in clinical and toxicological studies. The product has been endorsed by Food and Drug Administration of USA and FOSHU of Japan. The product also recommended by the US National Cholesterol Education Programme, the European Union Scientific Committee on Foods and the International Atherosclerosis society, he said.
Mr V S Reddy, Managing Director, British Biologicals, who also present on the occasion informed that his company which enjoys over 23 per cent of Indian Ethical nutrition Supplement Market has tied-up R&D with Raisio to produce Benecol and market it with its well-knit distribution network across the country. The company also plans to firm up a business partnership in Russia to market its wide range of products in the former communist country.
Mr V Sridhar, Executive Director, British Biologicals, who also spoke on the occasion has informed that company's strength lies in its research based nutrition supplement and with such research and development it would soon be launching products in specialities such as Orthopedics, Oncology, Nephrology and Cardiology shortly.
UNI MV RM HVB1732
Addressing newspersons here today Mr Mikkao Laavainen, Director, Raisio Nutrition Limited said that Raisio had entered into a business partnership with British Biologicals, and launch its Plant Stanon Ester 'Benecol' under the brand name Colred Benecol, a nutritional product, a supplement which reduce cholesterol naturally.
He said that Raisio had selected Bangalore based British Biolobicals, one of the top Indian company in nutraceuticals which manufactures varied products including B-Protin, D-Protin and Medi-Slim, to manufacture and market its product Colred Benecol in India and Asian Market.
Mr Laavainen also said that Raisio enjoyed over 30 per cent of the one billion USD global market of cholesterol reducing products with Europe was the predominant market. It is now being introduced in Asia, Africa and other Latin American countries, he said.
Rasio's Plant Stanol Ester-Benecol has proved its efficacy in controlling elevated cholesterol in 40 randomised controlled global clinical trials. There were no adverse effects in clinical and toxicological studies. The product has been endorsed by Food and Drug Administration of USA and FOSHU of Japan. The product also recommended by the US National Cholesterol Education Programme, the European Union Scientific Committee on Foods and the International Atherosclerosis society, he said.
Mr V S Reddy, Managing Director, British Biologicals, who also present on the occasion informed that his company which enjoys over 23 per cent of Indian Ethical nutrition Supplement Market has tied-up R&D with Raisio to produce Benecol and market it with its well-knit distribution network across the country. The company also plans to firm up a business partnership in Russia to market its wide range of products in the former communist country.
Mr V Sridhar, Executive Director, British Biologicals, who also spoke on the occasion has informed that company's strength lies in its research based nutrition supplement and with such research and development it would soon be launching products in specialities such as Orthopedics, Oncology, Nephrology and Cardiology shortly.
UNI MV RM HVB1732
Oneindia Login